Provided by Tiger Trade Technology Pte. Ltd.

Tempus AI

76.09
-0.4100-0.54%
Volume:2.85M
Turnover:223.18M
Market Cap:13.81B
PE:-53.07
High:80.31
Open:77.36
Low:75.80
Close:76.50
52wk High:104.32
52wk Low:40.77
Shares:181.56M
Float Shares:115.00M
Volume Ratio:0.70
T/O Rate:2.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4337
EPS(LYR):-1.4100
ROE:-67.44%
ROA:-8.55%
PB:31.05
PE(LYR):-53.96

Loading ...

GUIDANCE: (TEM) Tempus AI Expects Full Year 2026 Revenue Range $1.59B - $1.60B, vs. FactSet Est of $1.59B

MT Newswires Live
·
May 06

Tempus AI lifts 2026 revenue outlook

Reuters
·
May 06

Tempus Q1 net loss widens to $125.92 million; revenue rises 36.1% to $348.12 million

Reuters
·
May 06

Stock Track | Tempus AI Soars 10.91% Intraday on Strong Earnings Anticipation

Stock Track
·
May 01

Tempus AI CEO Eric Lefkofsky disposes of shares worth $8.54 million

Reuters
·
May 01

Tempus AI to host inaugural investor day, webcast available

Reuters
·
Apr 29

Earning Preview: Tempus AI Q1 revenue is expected to increase by 39%, and institutional views are bullish

Earnings Agent
·
Apr 28

Can Tempus AI’s (TEM) USC Partnership Quietly Redefine Its Clinical Data Moat?

Simply Wall St.
·
Apr 26

Press Release: Median Technologies Reports Full-Year 2025 Financial Results and Provides Key Q1 2026 Business Highlights

Dow Jones
·
Apr 23

AI Software Shares Slide. ServiceNow Down 16%; Atlassian Down 11%; Figma Down 9%; Workday Down 8%; Snowflake, Tempus AI Down Around 7%

Tiger Newspress
·
Apr 23

Tempus AI, USC Form Strategic Precision Medicine Partnership

MT Newswires Live
·
Apr 23

Tempus and Usc Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine

THOMSON REUTERS
·
Apr 23

Tempus AI Inc - Collaboration Includes Clinical Testing, Trial Matching, AI Care Pathways, and Research Co-Development

THOMSON REUTERS
·
Apr 23

Is Tempus AI (TEM) Pricing Reflect Its DCF Upside And Premium Sales Multiple

Simply Wall St.
·
Apr 23

Tempus, Adobe, Helus, Constellation, Stryker Trending With Analysts

TIPRANKS
·
Apr 18

Stock Track | Tempus AI Soars 5.56% Pre-Market on Gilead Partnership Expansion and Device Approval

Stock Track
·
Apr 17

Stock Track | Tempus AI Soars 5.11% in Pre-Market on Gilead Partnership Expansion and Device Approval

Stock Track
·
Apr 17

Stock Track | Tempus AI Plummets 5.60% Intraday on Profit-Taking After Product Announcement Surge

Stock Track
·
Apr 16

BUZZ-U.S. STOCKS ON THE MOVE-Nike, PNC Financia, OSI Systems

Reuters
·
Apr 16

Shares of Tempus AI up 8.7% After Deal With Predicta to Expand Access to Genome Test

THOMSON REUTERS
·
Apr 15